EV Biologics
Financial ratios & Valuation

Historical Multiples (2013 – 2023)

2013 2014 2015 2016 2017 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
5.894.425.53-0.38-12.85-3.27-365.06-15.09-0.58-8.06-0.02-12.85
Price/Sales ratio
1.391.061.030.470.74N/AN/A49.22N/A209.100.04N/A
Price/Book Value ratio
2.201.251.021.810.160.224.740.81-0.88-6.070.680.16
Price/Cash Flow ratio
5.213.907.741.534.57N/A369.828.38-0.58-3.110.19N/A
Price/Free Cash Flow ratio
-21.464.2411.49-0.87-18.69N/A369.82-0.31-0.58-3.07-0.07-18.69
Price/Earnings Growth ratio
N/A0.13-0.240.000.12N/A34.90-0.05-0.000.08-0.00N/A
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
36.95%38.13%36.48%38.64%16.24%N/AN/A100%N/A100%41.05%16.24%
Operating Profit Margin
33.22%34.22%27.81%7.71%0.55%N/AN/A-20.40%N/A-987.85%-324.74%N/A
Pretax Profit Margin
30.49%31.38%25.04%-116.85%-5.53%N/AN/A-326.07%N/A-2591.27%-140.36%N/A
Net Profit Margin
23.65%24.05%18.77%-124.72%-5.82%N/AN/A-326.07%N/A-2591.27%-140.81%N/A
Effective Tax Rate
22.43%23.36%25.03%-6.73%-5.26%174.64%208.46%61.01%1.08%13.25%-0.32%-5.26%
Return on Assets
17.60%15.37%11.18%-145.95%-0.93%-0.31%-1.09%-1.23%-184.31%-293.51%-215.98%-0.31%
Return On Equity
37.41%28.40%18.60%-472.17%-1.30%-6.75%-1.30%-5.37%152.20%75.27%-954.67%-6.75%
Return on Capital Employed
32.30%27.20%27.48%29.12%0.12%-6.75%-1.30%-0.33%4.26%28.69%-5410.37%-6.75%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.29N/A
Quick Ratio
0.991.930.850.403.100.200.070.020.020.180.220.22
Cash ratio
0.431.440.530.100.50N/A0.070.020.010.050.05N/A
Days of Sales Outstanding
64.2976.5947.2542.6339.74N/AN/A365N/A1.98K34.80N/A
Days of Inventory outstanding
4.285.604.525.095.76N/AN/AN/AN/AN/A2.51N/A
Operating Cycle
68.5782.1951.7747.7245.50N/AN/AN/AN/AN/A11.09N/A
Days of Payables Outstanding
20.7222.9021.2632.1276.42N/AN/AN/AN/AN/A27.51N/A
Cash Conversion Cycle
47.8459.2930.5115.59-30.91N/AN/AN/AN/AN/A7.91-30.91
Debt Ratios
Debt Ratio
0.190.110.090.150.100.32N/A0.691.983.460.900.10
Debt Equity Ratio
0.400.210.160.490.156.88N/A3.00-1.63-0.889.860.15
Long-term Debt to Capitalization
0.02N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
0.280.170.140.320.130.87N/A0.752.56-7.92N/A0.87
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-96.30N/A
Cash Flow to Debt Ratio
1.041.510.812.390.23N/AN/A0.03-0.91-2.19N/AN/A
Company Equity Multiplier
2.121.841.663.231.3921.231.184.34-0.82-0.2510.861.39
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
0.260.270.130.310.16N/AN/A5.86N/A-67.130.210.16
Free Cash Flow / Operating Cash Flow Ratio
-0.240.920.67-1.75-0.24N/A1-26.6011.01-2.67N/A
Cash Flow Coverage Ratio
1.041.510.812.390.23N/AN/A0.03-0.91-2.19N/AN/A
Short Term Coverage Ratio
1.111.510.812.390.23N/AN/A0.03-0.91-2.191.020.23
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A